Consideration of ATG-free therapy with eltrombopag and cyclosporine for severe aplastic anaemia

In The Lancet Haematology, Phillip Scheinberg and colleagues1 report the results of the SOAR trial, a multicentre, phase 2 trial investigating cyclosporine and eltrombopag combination therapy for patients with treatment-naive severe aplastic anaemia.